Preload Image
Preload Image

China Menopause Market Overview, 2030

China menopause market to grow at over 8.65% CAGR from 2025-30, fueled by urbanization and a rapidly aging female population.

The Chinese approach to care for menopause reflects the unique synergy between traditional Chinese herbal medicine TCM and modern biotechnology innovation. At the bottom of cultural heritage, MTC was a favorite choice for Chinese women to manage menopause symptoms. Plant-based formulations such as dang gui Angelica sinensis, il shou wu and ginneng are generally prescribed to balance yin and yang, improving traffic and reducing hot flashes, fatigue and emotional vibrations. These drugs are often supplied by tea, powders, or patented plants and are considered natural and natural alternatives to western hormone therapy. In parallel, China's biotechnology division, particularly innovative centres such as the Beijing Life Science Park, are conducting clinical research into menopause-free treatments. Companies are mimicking phototrophic nutrients, probiotic solutions, and synthetic hormones to mimic and combat the effectiveness of TCM with modern pharmacological validation. It should be noted that these biotech companies have built-in symptom monitoring platforms based on the personalized, the retention of the average city woman. Government support also plays an important role in this ecosystem. National Medical Products Agency NMPA has announced a new pathway for rapid monitoring for approval of plant medicines that stimulate businesses for innovation in the health segment during menopause. This led to the emergence of hybrid treatment protocols in urban hospitals where patients can be prescribed West additive, and formulas supported by formulas where patients are supported by biotechnology. As the age of the Chinese population, and by raising urban health awareness, the mixture of TCM and biotechnology is a model of cultural and global resonance for the treatment of menopause. China is positioned not only as a large internal market but also as a potential integrated solution for menopause in Asia and beyond.

According to the research report, "China Menopause Market Overview, 2030," published by Bonafide Research, the China Menopause market is anticipated to grow at more than 8.65% CAGR from 2025 to 2030. This growth will be promoted by the rapidly aging women population of the country, encouraging increased awareness of health and increased consumer readiness to invest in prevention and symptoms. Urbanization and lifestyle changes have a demand for traditional and modern solutions for menopause, food additives and plants based on non-acamoneal drugs and personalized health programs. An important feature of this market is the coexistence of traditional Chinese herbal medicine TCM and Western medicine, creating a variety of products. While TCM products continue to dominate the urban segment of rural and cultural, pharmaceutical innovation is becoming increasingly popular in metropolitan areas. Two plant agents and OTC synthetic drugs are often in high demand and are used simultaneously. Normative supervision is strictly strict National Management of Medical Products NMPA . For plant-based food-based foods, manufacturers must comply with strict documentation in accordance with Category III. On the pharmaceutical side, records of non-synthetic menopause, treatment, including records of cooled steam devices, mood steam devices, etc., according to chemical regulations, including data from clinical trials conducted in China. NMPA has introduced an accelerated path of innovative products aimed at chronic or age-related conditions, including menopause, as long as it meets safety standards and demonstrates therapeutic benefits. It is also recommended that businesses adhere to the standard Good Production Practices GMP and implement post-commerce monitoring systems. Due to the growth of national players' investments and international interest in China's consumer health market, the menopause segment is distinguished by both key areas of competence. It is created for both commercial success and the evolution of regulation within the NMPA framework.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample


In China, the menopause support market is by treatment is divided into Dietary Supplements and OTC pharma products. Food additives often contain plant-based ingredients traditionally used to support hormonal health and general wells during the ripe transition. Don Kai Angelica Sinensis, a well-known supplement across East Asia, is popular among well-known women for promoting hot epidemics, fatigue and mood fluctuations, especially among menopause women. Other foods include ingredients such as goji Bay, red dates, Chinese wells, and ginseng. Each was selected for updating the internal body system according to the principles of blood nutrition, increased blood circulation, and TCM. These additives are generally consumed in the form of capsules, powders or tonics and are directed at consumers looking for a preventive, holistic recreational solution. OTC proposals are more directly alleviated symptoms and are often classified into practical forms, consistent with the TCM composition. Plant-based spots are used directly in areas such as the stomach and back, and contain plant extracts absorbed from the skin, targeting local pain, hot flashes and fatigue. These modifications are widely available at retail pharmacies and TCM clinics. Balancing Tips, United herbs such as molten roots, chrysanthemums and black sesame are also commonly used to support sleep quality, emotional balance and temperature regulation. These teas act as cultural and functional tools that are deeply integrated into daily procedures. Product segmentation in China is distinguished by this double approach additives for long-term internal balance, and counter products for short-term relief. The market continues to develop as urban consumers are looking for pure, non-symbolic options, while rural areas maintain strong loyalty to traditional legal protections. These segments reflect a unique combination of Chinese cultural heritage and health development consumers.

In China, the menopause market by stages is pre menopause, menopause and post menopause. Major attention is taken to maintain smooth flow qi energy and nutritious blood prevent imbalances that can cause early symptoms of menopause. Chinese women consume food additives and tonics with ingredients such as ginseng, gerja, and astragal berry to create durability and improve regulation of menstrual cycles. These practices aim to maintain vitality and delay at the onset of hormonal oscillations. While women arrive at menopause, TCM highlights the recovery of Balance in Yang, which is supposed to be interrupted by a decrease in kidney energy. Treatment moves to cooling herbs, like Quai, Rahmanian, and licorice roots. Herbal tea, acupuncture, pressure points are generally used to naturally control this phase, often without pharmaceutical hormones. After menopause, priority changes to support the aging organ, especially the bone, skin and immune system. Women often take TCM Rich Supplement, which is rich in calcium and rich in black sesame seeds, nuts and other ingredients. The main attention is paid to maintaining elegant aging, flexibility, and clarity of mental and bone health. Practices such as Tai Chi and Qigong will also allow perceptibility to their role in maintaining energy flow, joint function, and emotional stability. Chinese women view menopause as a natural transformation, not as a condition that they must treat. By asserting in the TCM philosophy, they follow the path of recovery, adapting to each stage of life and creating a segmented healing journey, but uniting on tradition for centuries.

The menopause market in China by distribution channel is divided into hospitals, retail and online platforms. The Chinese menopause market demonstrates a distinctive mix of medical approaches to the West and East, clearly reflected in its health distribution channels. Hospital PharmacyIn urban centres like Beijing and Shanghai, it plays a dual role. They offer hormonal therapy based on recipes based on Western medicine. The major hospitals work with gynecologists and TCM experts to incorporate two systems under one roof that provides a menopause adapted to each patient's symptoms and preferences. ? This is understood. On the contrary, Retail Pharmacy - first, a request for products on the counter OTC of TCM, including both national networks and district sales points. These include plant-based tea, cooling areas, vaginal moisturizers, and stress delivery. Women often consult with TCM pharmacists in the store for advice and choose from a wide range of products aimed at a yin and yang balance to calm the hot outbreak or support liver and kidney health. These products are preferred by those who prefer to naturally control symptoms, or to perfect recipes that contain food. Meanwhile, online trading platforms such as JD.com, Alibaba Tmall Pharmacy and Ping of a Good Doctor have become powerful platforms for the electronic farming space, particularly for young people and technical consumers. These platforms provide nationwide access to both Western drugs and TCM additives that are often associated with AI-based virtual consultations and symptoms. Their coverage is particularly important in second and third levels of cities where special menopause may be limited. Furthermore, the convenience, confidentiality and various e-companies are responding to the rise in digital health trends across China. The Chinese menopause canal reflects synergistic health ecosystem, unwavering traditional beliefs, modern clinical practices, and advanced e-commerce infrastructure to meet the needs of various consumers.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Sikandar Kesari

Research Analyst



Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Menopause Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Treatment
• Dietary Supplements
• OTC pharma products

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Sikandar Kesari


By Stages
• Menopause
• Pre-menopause
• Post-menopause

By Distribution Channels
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

Table of Contents

  • 1. Executive Summary
  • 2. Market Structure
  • 2.1. Market Considerate
  • 2.2. Assumptions
  • 2.3. Limitations
  • 2.4. Abbreviations
  • 2.5. Sources
  • 2.6. Definitions
  • 3. Research Methodology
  • 3.1. Secondary Research
  • 3.2. Primary Data Collection
  • 3.3. Market Formation & Validation
  • 3.4. Report Writing, Quality Check & Delivery
  • 4. China Geography
  • 4.1. Population Distribution Table
  • 4.2. China Macro Economic Indicators
  • 5. Market Dynamics
  • 5.1. Key Insights
  • 5.2. Recent Developments
  • 5.3. Market Drivers & Opportunities
  • 5.4. Market Restraints & Challenges
  • 5.5. Market Trends
  • 5.6. Supply chain Analysis
  • 5.7. Policy & Regulatory Framework
  • 5.8. Industry Experts Views
  • 6. China Menopause Market Overview
  • 6.1. Market Size By Value
  • 6.2. Market Size and Forecast, By Treatment
  • 6.3. Market Size and Forecast, By Stages
  • 6.4. Market Size and Forecast, By Distribution Channels
  • 6.5. Market Size and Forecast, By Region
  • 7. China Menopause Market Segmentations
  • 7.1. China Menopause Market, By Treatment
  • 7.1.1. China Menopause Market Size, By Dietary Supplements, 2019-2030
  • 7.1.2. China Menopause Market Size, By OTC pharma products, 2019-2030
  • 7.2. China Menopause Market, By Stages
  • 7.2.1. China Menopause Market Size, By Menopause, 2019-2030
  • 7.2.2. China Menopause Market Size, By Pre-menopause, 2019-2030
  • 7.2.3. China Menopause Market Size, By Post-menopause, 2019-2030
  • 7.3. China Menopause Market, By Distribution Channels
  • 7.3.1. China Menopause Market Size, By Hospital Pharmacy, 2019-2030
  • 7.3.2. China Menopause Market Size, By Retail Pharmacy, 2019-2030
  • 7.3.3. China Menopause Market Size, By Online Pharmacy, 2019-2030
  • 7.3.4. China Menopause Market Size, By Others, 2019-2030
  • 7.4. China Menopause Market, By Region
  • 7.4.1. China Menopause Market Size, By North, 2019-2030
  • 7.4.2. China Menopause Market Size, By East, 2019-2030
  • 7.4.3. China Menopause Market Size, By West, 2019-2030
  • 7.4.4. China Menopause Market Size, By South, 2019-2030
  • 8. China Menopause Market Opportunity Assessment
  • 8.1. By Treatment, 2025 to 2030
  • 8.2. By Stages, 2025 to 2030
  • 8.3. By Distribution Channels, 2025 to 2030
  • 8.4. By Region, 2025 to 2030
  • 9. Competitive Landscape
  • 9.1. Porter's Five Forces
  • 9.2. Company Profile
  • 9.2.1. Company 1
  • 9.2.1.1. Company Snapshot
  • 9.2.1.2. Company Overview
  • 9.2.1.3. Financial Highlights
  • 9.2.1.4. Geographic Insights
  • 9.2.1.5. Business Segment & Performance
  • 9.2.1.6. Product Portfolio
  • 9.2.1.7. Key Executives
  • 9.2.1.8. Strategic Moves & Developments
  • 9.2.2. Company 2
  • 9.2.3. Company 3
  • 9.2.4. Company 4
  • 9.2.5. Company 5
  • 9.2.6. Company 6
  • 9.2.7. Company 7
  • 9.2.8. Company 8
  • 10. Strategic Recommendations
  • 11. Disclaimer

Table 1: Influencing Factors for Menopause Market, 2024
Table 2: China Menopause Market Size and Forecast, By Region (2019 to 2030F) (In USD Million)
Table 3: China Menopause Market Size of Dietary Supplements (2019 to 2030) in USD Million
Table 4: China Menopause Market Size of OTC pharma products (2019 to 2030) in USD Million
Table 5: China Menopause Market Size of Menopause (2019 to 2030) in USD Million
Table 6: China Menopause Market Size of Pre-menopause (2019 to 2030) in USD Million
Table 7: China Menopause Market Size of Post-menopause (2019 to 2030) in USD Million
Table 8: China Menopause Market Size of Hospital Pharmacy (2019 to 2030) in USD Million
Table 9: China Menopause Market Size of Retail Pharmacy (2019 to 2030) in USD Million
Table 10: China Menopause Market Size of Online Pharmacy (2019 to 2030) in USD Million
Table 11: China Menopause Market Size of Others (2019 to 2030) in USD Million
Table 12: China Menopause Market Size of North (2019 to 2030) in USD Million
Table 13: China Menopause Market Size of East (2019 to 2030) in USD Million
Table 14: China Menopause Market Size of West (2019 to 2030) in USD Million
Table 15: China Menopause Market Size of South (2019 to 2030) in USD Million

Figure 1: China Menopause Market Size By Value (2019, 2024 & 2030F) (in USD Million)
Figure 2: Market Attractiveness Index, By Treatment
Figure 3: Market Attractiveness Index, By Stages
Figure 4: Market Attractiveness Index, By Distribution Channels
Figure 5: Market Attractiveness Index, By Region
Figure 6: Porter's Five Forces of China Menopause Market
Logo

China Menopause Market Overview, 2030

ChatGPT Summarize Gemini Summarize Perplexity AI Summarize Grok AI Summarize Copilot Summarize

Contact usWe are friendly and approachable, give us a call.